We’re looking for a highly motivated Marketing Intern to join our Marketing team.In this role, you’ll collaborate closely with our Global Marketing Manager to support a wide range of initiatives across digital marketing, communications and branding. You’ll play a key and hands-on role in executing brand strategies and digital campaigns designed to increase brand awareness, […]
KYBORA, a global healthcare advisory firm and investment bank, and Foundation Rwanda, a nonprofit organization committed to supporting survivors of the 1994 genocide against the Tutsi, recently co-hosted a benefit dinner in Princeton, New Jersey. The event brought together leaders from the biopharma sector in support of a shared mission: empowering second-generation genocide survivors through […]
Episode 4: ALS Innovation: Where Science is Leading Us In our latest episode, Raya Therapeutic Founder, Anjan Aralihalli, joins KYBORA‘s CEO, Alan Vanderborght, for an inspiring and in-depth conversation exploring Anjan’s background and journey, groundbreaking developments in ALS research and the path that led to the creation of Raya Therapeutic. Listen to their conversation below:
KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Gonçalo Marques has joined the company as an Associate. Gonçalo gained experience in healthcare M&A advisory, working with private equity and corporate clients across Europe on transactions covering the full healthcare spectrum. Prior to joining KYBORA, he held roles at Houlihan Lokey […]
Episode 3: Inside China’s R&D powerhouse: Strategic Insights for Pharma leaders In our third episode, KYBORA‘s CEO, Alan Vanderborght, sits down with Dr. Weiyong Sun, Chief Business Officer at Hansoh Bio, for a thought-provoking conversation on some of the most pressing issues in the pharmaceutical industry. Together, they explore a range of topics — including […]
The biopharma industry is at a turning point: will your leadership lead your company to success or make it fall behind? Breakthroughs in AI, genomics, and digital health are revolutionizing how therapies are developed and delivered. At the same time, regulatory shifts, market dynamincs, and rising competition are pressuring companies to rapidly adapt. Our new […]
KYBORA, a global healthcare advisory firm and investment bank, is proud to announce that Vladyslava Bab’yak has joined the company as an Analyst. With a double Master’s degree in Finance with honors from the School of Business, Economics and Law in Gothenburg, and the University of Rome Tor Vergata, Vladyslava brings an analytical mindset and international […]
Episode 2: Biopharma Today: Tariff Pressures and Industry Transformation In our second episode, Biopharma Today: Tariff Pressures and Industry Transformation, host Alan Vanderborght, CEO of KYBORA, welcomes guest Carlo de Notaristefani, President at CDN Advising.They engage in a discussion about Carlo’s extensive experience, supply chain management, tariff pressures and the evolution of the Biopharma industry. […]
A Strategic Vision for Healthcare Expansion – Setting the stage for continued growth in 2025 For many small and medium-sized enterprises (SMEs) in the life sciences sector, the path to scaling up, innovation and expansion can be blocked by regional limitations, resource constraints, and the complexities of global markets access. This was the case for […]
The biotech industry has experienced a dramatic shift since 2022. After the pandemic-era boom, the sector entered a “tumble” marked by slashed budgets, reduced headcounts, and cautious financial stewardship (6 Predictions for Healthcare and Biotech in 2024｜Audacity Health). Small to mid-sized biotech companies – from early-stage startups to publicly traded micro-caps – now face a […]
